Prognostic Value of EGFR Mutation and ERCC1 in Patients with Non-Small Cell Lung Cancer Undergoing Platinum-Based Chemotherapy

BACKGROUND: In order to improve the outcome of patients with non-small cell lung cancer (NSCLC), a biomarker that can predict the efficacy of chemotherapy is needed. The aim of this study was to assess the role of EGFR mutations and ERCC1 in predicting the efficacy of platinum-based chemotherapy and...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamashita, Fumie, Azuma, Koichi, Yoshida, Tsukasa, Yamada, Kazuhiko, Kawahara, Akihiko, Hattori, Satoshi, Takeoka, Hiroaki, Zaizen, Yoshiaki, Kawayama, Tomotaka, Kage, Masayoshi, Hoshino, Tomoaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3734014/
https://www.ncbi.nlm.nih.gov/pubmed/23940741
http://dx.doi.org/10.1371/journal.pone.0071356

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3734014/
https://www.ncbi.nlm.nih.gov/pubmed/23940741
http://dx.doi.org/10.1371/journal.pone.0071356

Ejemplares similares